radiation oncology - search results
If you're not happy with the results, please do another search
“We started off with chinagraphs”: The evolution of radiation oncology
Liz Kenny of the Royal Brisbane and Women’s Hospital (Brisbane, Australia) gave her radiation oncologist’s take on the “120-odd-year” history of radiation therapy, how...
Trans-Tasman Radiation Oncology Group (TROG) Annual Scientific Meeting
W: www.trog.com.au
Imaging-guided sister disciplines radiation oncology and interventional oncology “should build on common ground”
Collaboration in matters of training, research and clinical practice between radiation oncology (RO) and interventional oncology (IO) could significantly advance research into local therapies, benefit patients...
PAIRS 2023: How dogs with seizures inspired novel neuro-oncology trial
On day two of the Pan Arab Interventional Radiology Society annual meeting (PAIRS; 11–14 February, Dubai, UAE), Riad Salem (Northwestern University, Chicago, USA) took...
Study shows promising safety, patient outcomes data for MRI-guided adaptive radiation therapy to treat...
Findings from a recent prospective study show promising safety and patient outcomes data for locally advanced and borderline resectable pancreatic cancer treatment using ablative...
Micromate™ reduces complications, radiation exposure and procedure time for increasingly “challenging” cases
This advertorial is sponsored by Interventional Systems.
Marco van Strijen is an interventional radiologist at St Antonius Ziekenhuis (Nieuwegein, The Netherlands) who specialises in non-vascular...
Ablation planning: “Interventional oncology must become reliable and reproducible”
Reto Bale (Medizinische Universität Innsbruck, Innsbruck, Austria) gave a presentation titled ‘Stereotactic thermal ablation—can it break the current limits?’ at the 2022 European Conference...
New consensus guidelines will facilitate interventional oncology research
We are facing several problems in the field of clinical oncology research, by which I mean that study results are being collected, analysed and...
IASIOS, the world’s first accreditation programme for interventional oncology, just opened for public enrolment
The International Accreditation System for Interventional Oncology Services (IASIOS) has passed its pilot phase with flying colours, the Cardiovascular and Interventional Radiological Society of...
Interventional Oncology 2.0: Soul-searching to define our identity
Julius Chapiro and Lynn Savic claim there is “no need for scepticism” about the recent emergence and growth of immuno-oncology from an interventional oncologists’...
Ultrasound-only guidance for cryoablation procedures eliminates radiation burden in children
Ultrasound-only guidance is technically feasible for a substantial proportion of cryoablation procedures, Alex Barnacle (Great Ormond Street Hospital, London, UK) reported at the 2019...
Nanotechnology answers outstanding clinical questions in interventional oncology
“Interventional radiology is uniquely equipped to shape the next generation of nanotherapeutics,” Sarah White, associate professor of Radiation and Surgical Oncology at the Medical...
Society of Interventional Oncology requests updates to NCCN guidelines to more strongly recommend ablation
The Society of Interventional Oncology (SIO) is working more closely within cooperative groups and taskforces, as well as amongst the guidelines commentariat, to provide...
Interventional oncology established in “mainstream” cancer care with world-first clinical symposium
The world-first collaboration between interventional oncology (IO) and radiation oncology, embraced by the Trans-Tasman Radiation Oncology Group (TROG), continues to bear fruit, with the...
Potential synergies of immuno-oncology with interventional oncology
The questions of if, how and when to combine interventional oncological procedures with systemic immunotherapy are on the tip of everyone’s tongue, from multidisciplinary tumour boards...
WCIO session highlights the pick of recent interventional oncology research
A session at the World Conference on Interventional Oncology (WCIO; 8–11 June, Boston, USA), organised by the Society of Interventional Oncology (SIO), identified the...
Adding interventional oncology to immuno-oncology
Some research data suggest there could be a synergistic effect between immunotherapy and minimally invasive procedures. Tumour types that do not respond to checkpoint...
BTG and SIO to explore role of minimally invasive therapies in immuno-oncology
BTG has announced a collaboration with the Society of Interventional Oncology (SIO; a global organisation working to nurture and support interventional oncology worldwide) to...
Learn the language of oncology
The World Conference on Interventional Oncology (WCIO) is developing an online interventional oncology curriculum called IO University. Michael Soulen, immediate past chair of the...
The challenges of measuring response in interventional oncology
An overview of three treatments: ablation, chemoembolization and selective interval radiation therapy, should clarify the challenges of determining tumour response in interventional oncology, write Maxime Ronot and Val̩rie Vilgrain.
Interventional oncology: The next oncological discipline
Andreas Adam (King’s College, London, UK) talks to ecancertv at NCRI 2014 about interventional oncology, which joins surgery, radiation oncology and medical oncology and...
SIR-Spheres recommended in new oncology clinical guidelines for treatment of metastatic colorectal cancer
Newly published European Society for Medical Oncology (ESMO) clinical guidelines for the treatment of metastatic colorectal cancer endorse radioembolisation, specifically with yttrium-90 (Y90) resin...
Radiation protection a “key theme” at ECR
The European Congress of Radiology (ECR) saw the launch of the EuroSafe Imaging campaign, an initiative promoting appropriateness in medical imaging, maintaining doses within diagnostic reference levels and emphasising the as low as reasonably achievable (ALARA) principle.
The difference between technician and oncologist will take interventional oncology where it should be
Radiation oncologist, Lizbeth Kenny from Queensland, Australia, showed the way to interventional oncologists at the ECIO meeting (25–28 April, Florence, Italy).
Kenny, medical director, Central...
“Both interventional radiologists and radiation oncologists would benefit from an alliance”
Adam, London, UK, who has been president of every major radiology and interventional radiology association in Europe, including CIRSE, the European Society of Radiology...
ViewRay receives FDA 510(k) clearance for MRI-guided radiation therapy system
ViewRay has received US FDA 510(k) premarket notification clearance for its MRI-guided radiation therapy system. The ViewRay system features a combination of radiotherapy delivery and...
Interventional radiology and radiotheranostics: When talent meets innovation
Interventional radiology (IR) is a main player in modern clinical oncology practice. Almost every tumour board has a seat for IR. Clinical oncology is...
Editor’s letter: Beyond needles and images
Interventional radiology (IR) is unique amongst procedural disciplines because its ‘parent specialty’ is a diagnostic discipline that has no infrastructure for clinical practice. Charles...
“Doing better” for IR in Australia and New Zealand, from specialty status to qualification
Interventional radiologist Nick Brown is clinical director of the radiology service at The Wesley Hospital (Auchenflower, New Zealand) and associate professor at the University...
ABK Biomedical announces IDE approval for multicentre pivotal study of Eye90 microspheres in HCC
ABK Biomedical has received approval for its investigational device exemption (IDE) application from the US Food and Drug Administration (FDA) to commence a multicentre...
SBRT could be an “effective” treatment for patients with lung neuroendocrine tumours
Researchers at Moffitt Cancer Center (Tampa, USA) are investigating new treatment approaches for the primary lung neuroendocrine tumour patient population. In a new article published...
Dimitrios Filippiadis
“The spine is an area where interventional radiologists play a crucial role in both diagnosis and therapeutic management of a variety of pathologies”.
Dimitrios...
ECIO 2022 sees launch of landmark foundation IO course: Q&A with Philippe Pereira
The 2022 European Congress on Interventional Oncology (ECIO) took place 24–27 April in Vienna, Austria. Interventional News spoke to chairman Philippe Pereira (SLK-Kliniken, Stuttgart,...
Interventional News’ top 10 most read articles of April 2022
A report from the American Venous Forum (AVF) 2022 meeting (23–26 February, Orlando, USA) on the comparative merits and demerits of dedicated and non-dedicated...
SIO 2022: ‘Controversies’ in current cancer treatment
One of the sessions at this year’s Society of Interventional Oncology (SIO) meeting (24–28 March, San Francisco, USA) comprised four debates moderated by David...
Cardiovascular Coalition urges Congress, CMS to reverse proposed Medicare cuts during PAD Awareness Month
The CardioVascular Coalition (CVC), a coalition of physicians, care providers, advocates, and manufacturers working to improve awareness and prevention of peripheral arterial disease (PAD),...
SIR publishes new position statement and quality improvement document on percutaneous lung ablation
The Society of Interventional Radiology (SIR) has issued a new position statement on percutaneous lung ablation in the August edition of the Journal of...
SIR 2021 Abstract of the Year: OPuS One data “should move the needle more”...
NOTE: This video is ONLY available to watch in selected countries and geographies
Jason Levy (Atlanta, USA) and Elizabeth David (Toronto, Canada) talk to Interventional...
Canon launches CT scanner with 90cm bore at ASTRO 2020
Canon Medical Systems has launched its Aquilion Exceed LB (pending 510(k) clearance), a CT scanner dedicated to radiation therapy planning, at this week's American...
Matthew Callstrom
President-elect of the Society of Interventional Oncology (SIO), Matthew Callstrom discusses his journey into cancer care, and how advances in percutaneous ablation have shaped...
International accreditation scheme “brings IO into the mainstream”
The newly established International Accreditation System for Interventional Oncology Services (IASIOS) gives medical facilities the opportunity to receive credentials for their interventional oncology (IO)...
CMSS “strongly urges action” to ensure all frontline healthcare professionals are protected
In a new statement published on 2 April 2020, all 45 societies represented by the US Council of Medical Specialty Societies (CMSS)—over 800,000 physicians—emphatically...
American Board of Radiology announces November dates for Core Exam
The American Board of Radiology (ABR) has announced that its Core Exam for diagnostic radiology (DR) and interventional radiology (IR/DR) will be held in...
SBRT offers good disease control out to five years in men with locally recurrent...
Stereotactic body radiation therapy (SBRT) in previously irradiated patients “appears clinically feasible”, and provides good disease control out to five years for men with...
Ricardo García-Mónaco
Establishing the first Interventional Radiology department in Argentina, Ricardo García-Mónaco is a pioneer of minimally invasive, image-guided therapies in South America. Looking back on...
Immunotherapy “destined to become an integral part of IO care”
“It is very important that we, as interventional oncologists, embrace the immuno-oncology field,” Thierry de Baère (Institut Gustave Roussy, Villejuif, France) said in his...
Ablation cheaper than Y-90 or TACE for the treatment of hepatocellular carcinoma
Ablation costs are significantly less than those of transarterial chemoembolization (TACE) and Yttrium-90 (Y-90), according to a comparative cost analysis of the three...
Alex Tang
“Deep in my heart, I knew interventional radiology (IR) had a tremendous future,” Alex Tang tells Interventional News. Looking back at his career, Tang...
SIRT approved for routine commissioning on the NHS
National Health Service (NHS) England have announced that selective internal radiation therapy (SIRT) using yttrium-90 (Y-90) microspheres will now be routinely commissioned for NHS...
Together, IO and RO can increase the scope of local tumour treatment
Bringing interventional oncology (IO) and radiation oncology (RO) closer together would yield more than important logistical gains for IO; it would open up a...
Gerard Goh
President of the Interventional Radiology Society of Australasia (IRSA) and European Board of Interventional Radiology (EBIR) examiner for Australia and New Zealand, Gerard Goh...
Interventional Radiology profile rises in medicine and at RSNA meeting
For the first time at an annual meeting of the Radiological Society of North America (RSNA; 25–30 November, Chicago, USA), interventional radiology (IR) companies...
Interventional News Issue 70 – June 2018 US Edition
Issue highlights:
Imaging-guided sister disciplines radiation oncology and interventional oncology “should build on common ground”
UK’s NICE recommends prostate artery embolization for selected men...
Interventional News Issue 70 – June 2018
Issue highlights:
Imaging-guided sister disciplines radiation oncology and interventional oncology “should build on common ground”
UK’s NICE recommends prostate artery embolization for selected men...
Stephen B Solomon
Stephen B Solomon, chief, Interventional Radiology Service, Memorial Sloan Kettering Cancer Center, New York, USA and president of the Society for Interventional Oncology (SIO)...
Registries will help determine survival of IO as a specialty
The primary importance of collecting data from registries would be to establish outcome data to prove the value of the interventional oncologic therapies to healthcare...
First patient treated with vandetanib-eluting beads that are visible on CT scans
Researchers from the University College London (UCL) Cancer Institute, London, UK, and BTG have begun the first clinical trial of an experimental treatment for...
Liz Kenny receives prestigious Officer of the Order of Australia award
Internationally-renowned radiation oncologist, Lizbeth (Liz) Kenny, has received her badge as an Officer of the Order of Australia. The investiture ceremony was on 4 May...
Artificial intelligence virtual consultant could guide interventional radiology patient care
Interventional radiologists at the University of California at Los Angeles (UCLA), Los Angeles, USA, are using technology found in self-driving cars to power a...
Gregory John Slater
"War (as in turf war) is an emotional word because, in wars, people get hurt. I believe we truly care about the patients we...
New NCCN guidelines recommend SIRT for the treatment of metastatic colorectal cancer
Sirtex has announced that SIR-Spheres Y-90 resin microspheres have been included as a Category 2A recommended treatment in the latest National Comprehensive Cancer Network...
SIRT Users’ Network announces European expansion
The SIRT Users' Network of professionals who treat liver cancer is to extend across the UK, Belgium, Spain and Italy
The success of the SIRT Users' Network,...
Constantinos T Sofocleous
“As interventional radiology is established as a free-standing specialty, an international outreach effort to establish guidelines for different interventional treatments is certainly needed,” Constantinos...
Immunotherapy could transform systemic power of locoregional IO treatments
Many physicians now believe that immunotherapy is a disruptive field in cancer medicine. Interventional oncology can either “snooze and lose” as one prominent interventional...
Treatment results of SIR-Spheres Y-90 resin microspheres similar regardless of patient age
A new analysis of the MORE data on 606 mCRC patients treated with SIR-Spheres’ Y-90 resin microspheres at 11 US medical centres confirms that patient age is not a barrier to appropriate treatment.
SIRFLOX trial results to be presented at ASCO
The SIRFLOX trial results will be presented by Peter Gibbs, co-principal investigator of the SIRFLOX trial, in the oral abstract session on gastrointestinal (colorectal) cancer at the American Society for Clinical Oncology (ASCO) annual meeting in Chicago, USA, on Saturday, 30 May 2015.
First US trial to assess combination therapy with intraoperative radiotherapy and kyphoplasty begins
Kypho-IORT (Combining intraoperative radiotherapy with kyphoplasty for treatment of spinal metastases) will test a new combination treatment that delivers radiation directly to the tumour and increases support of the spine.
MORE study data provide insight into predicting SIRT treatment outcomes
Investigators from the MORE (Metastatic colorectal cancer liver metastases outcomes after radioembolization) study have released new findings at the American Society of Clinical Oncology’s 2014 Gastrointestinal...
Interventional oncologists begin running US National Cancer Institute cooperative group trial
An important opportunity has opened up for interventional oncologists as WCIO leaders take the helm of the E1208 trial. Michael C Soulen writes that...
Liz Kenny
Internationally-renowned radiation oncologist, Liz Kenny, a longstanding supporter of interventional radiology, shares her views in Interventional News. Kenny, who is a senior radiation oncologist...
Sirtex to distribute Surefire Medical’s infusion system in Australia and Asia-Pacific markets
Sirtex Medical and US-based Surefire Medical has announced a sales and marketing partnership to distribute Surefire’s range of innovative infusion systems and specialty catheters for the...
Radiosurgery treatments for lung cancer using Varian Medical Systems Technologies presented at ESTRO
Detailed experiences of stereotactic ablative body radiotherapy (SABR) treatments using Varian’s TrueBeam medical linear accelerator and Calypso “GPS for the Body” tumour-tracking technology were...
First centre in Hong Kong treats patients with CyberKnife and TomoTherapy systems
Accuray announced that the Hong Kong Adventist Oncology Center, the first centre locally to offer both the CyberKnife Robotic Radiosurgery and TomoTherapy systems, hosted its...
Surefire Medical infusion system can prevent embolics entering non-target vessels for the treatment of...
Surefire Medical’s new infusion system maximises delivery of drugs directly to the tumour site while minimising potential damage to non-target organs, according to a...
CyberKnife VSI System now in India
Accuray Incorporated has announced that Medanta – The Medicity Cancer Institute, and the Roentgen-BLK Super Speciality Hospital both recently acquired and started treating patients...
Interventional radiology in the USA now a primary specialty in medicine
On 11 September, the American Board of Medical Specialties (ABMS) recognised the unique interventional radiology skill set with the new dual certificate in interventional radiology and diagnostic radiology.
Anticipated highlights of WCIO 2012
The World Conference on Interventional Oncology (WCIO) will promote dialogue on available and emerging minimally invasive oncologic therapies at the Sheraton Chicago Hotel and...
Varian, Siemens form radiotherapy and radiosurgery collaboration
On 25 April, Varian Medical Systems and Siemens Healthcare announced the signing of a strategic global partnership to provide advanced diagnostic and therapeutic solutions...
TomoTherapy announces first Middle East installation of Hi‰Û¢Art cancer treatment system
Saudi Arabia‰Ûªs King Faisal Specialist Hospital & Research Centre will become region‰Ûªs first to treat cancer patients with next-generation radiation therapy solution.
SIO president sets sights on becoming “strongest voice for the IO community”
Muneeb Ahmed is an interventional radiologist specialising in interventional oncology (IO) at Beth Israel Deaconess Medical Centre (Boston, USA) and current president of the...
Micromate: Your robotic assistant for all needle interventions from head to toe
This advertorial is sponsored by Interventional Systems.
Achieving consistency, accuracy, and ease of use in interventional radiology (IR) and interventional oncology (IO) procedures, including biopsy...
Boston Scientific receives 510(k) clearance for expanded cryoablation system
Boston Scientific has received 510(k) clearance for expanded indication of the Visual Ice cryoablation system. The clearance grants this device an indication expansion to...
New renal technologies: From radial access to angio-CT
Olivier Pellerin (Université de Paris, Paris, France) presented on technological updates in the renal space at the Global Embolization Oncology Symposium Technologies meeting (GEST;...
Pooled analysis data from 580 patients with unresectable HCC reinforce positive outcomes of LifePearl...
This advertorial is sponsored by Terumo Interventional Systems
LifePearl™ microspheres (Terumo) are polyethylene glycol (PEG) embolization microspheres that can be loaded with chemotherapeutic drugs including...
Multidisciplinary approach to MSK cancer treatment needs “gaps” filling
Dimitrios Filippiadis (National and Kapodistrian University of Athens , Athens, Greece) was the final speaker to take to the podium at the European Conference...
GE HealthCare introduces solution to expand interventional CT access
GE HealthCare is further advancing its precision care strategy with CT-Navigation, which offers clinicians detailed, real-time, 3D computed tomography (CT) images for stereotactic needle...
Speakers shine light on current evidence for the ‘IOs’ and the gaps therein
Two of the sessions from day one of the 2023 European Conference on Interventional Oncology (ECIO; 16–19 April, Stockholm, Sweden) drew delegates’ focus to...
Interventional News’ top 10 most popular stories of February 2023
Interventional News’ most popular stories for the month of February included news from the Pan Arab Interventional Radiology Society annual meeting (PAIRS; 11–14 February,...
PAIRS 2023: What the BCLC guidelines have omitted
Sarah White (Medical College of Wisconsin, Milwaukee, USA) opened the liver interventional oncology (IO) session at the Pan Arab Interventional Radiology Society (PAIRS) annual...
Histotripsy: New technology making waves in IO
Mina S Makary, assistant professor at the Division of Vascular and Interventional Radiology/Department of Radiology at the Ohio State University Wexner Medical Center (Columbus,...
HKUMed discovers new trimodality therapy for locally advanced liver cancer
A phase II clinical study on a trimodality therapy (START-FIT), conducted by the Departments of Surgery and Clinical Oncology, School of Clinical Medicine, University...
BSIR faculty highlights specialty developments worth watching
In the opening session of the British Society of Interventional Radiology (BSIR) annual scientific meeting 2022 (2–4 November, Glasgow, UK) titled ‘What’s up, Doc?’,...
AI and VR in IR: Interventional radiology technologies now and in the future
The Cardiovascular and Interventional Radiological Society of Europe (CIRSE) 2022 annual meeting (10–14 September, Barcelona, Spain) saw presenters explore artificial intelligence (AI), its current...
Authors receive accolade of ‘Abstract of the Year’ at SIR 2022
At the Society of Interventional Radiology (SIR) 2022 Annual Meeting (11-16 June, Boston, USA), four of the abstracts submitted were declared ‘Abstract of the...
Holmium-166 SIRT demonstrates safety and efficacy in the treatment of HCC
University Medical Center Utrecht (Utrecht, Netherlands) recently published the latest results from the HEPAR Primary study, which evaluated the safety and efficacy of Holmium-166...
Yasuaki Arai
“I do not want interventional radiology to be a treatment for the rich, nor for those who live in the wealthiest countries.” Yasuaki Arai...
(Re)defining curative intent for HCC
Global Embolization Oncology Symposium Technologies (GEST; 19–22 May, New York, USA) provided delegates and faculty alike with the opportunity to hear about worldwide approaches...
EPOCH trial reignites radioembolization as treatment for colorectal liver metastases
In the trial, radioembolization (also called selective internal radiation therapy ) using glass beads (Therasphere; Boston Scientific) containing radioactive yttrium (Y-90) was used as...
BSIR 2021: Interventional radiologists rev up on IR registry and build strong case for...
The British Society for Interventional Radiology (BSIR) has set up an interventional radiology (IR) registry to capture a glimpse of the scope, breadth and...
Cryoablation could freeze out lumpectomy in early-stage, low-risk breast tumours
A pilot study, published in the Journal of Cancer Therapy, reveals that percutaneous cryoablation of early-stage, low-risk breast cancer tumours smaller than 15mm presents a...
Sarasota team completes “world first” procedure with ACE Xtend robotic system
XACT Robotics today announced what it describes as the world’s first remote-controlled robotic instrument insertion and non-linear steering during an interventional oncology percutaneous procedure...
ECLIPSE shows cryoablation effective for local control of pulmonary long-term metastatic tumours
Cryoablation is effective for local tumour control in patients with pulmonary metastatic disease. Within the ECLIPSE study, cryoablation had no significant impact on the...
Late-breaking data indicate improved progression-free survival following TheraSphere treatment
Late-breaking trial data has demonstrated improved progression-free survival in patients with metastatic colorectal cancer after treatment with TheraSphere Y-90 Glass Microspheres (Boston Scientific).
Findings from...
Radioembolization can be used as a bridge to surgery in HCC patients, ET audience...
Using selective internal radiation therapy (SIRT) to down-stage hepatocellular carcinoma (HCC) tumours or act as a bridge to surgery is feasible for both small...
HEPAR Primary study demonstrates safety of 166Ho-radioembolization in HCC, lays foundation for individualised cancer...
This article is sponsored by Terumo Interventional Systems.
Holmium-166 (166Ho) radioembolization is a safe treatment option for patients with hepatocellular carcinoma (HCC), show results from...
COLDFIRE 2: IRE is safe, effective in patients unsuitable for thermal ablation or surgery
Irreversible electroporation (IRE) is an effective and relatively safe treatment for colorectal liver metastases 5cm or smaller that are deemed unsuitable for partial hepatectomy,...
Interventional News’ top 10 most popular stories for April 2021
Three of our top 10 stories of April 2021 highlight new data and ideas presented at this year's Charing Cross (CX) Symposium, Digital Edition...
Interventional News’ top 10 most popular stories for February 2021
Our top 10 stories of February 2021: a success story for interventional oncology as intra-arterial delivery of chemotherapeutic agents is shown to improve survival,...
IO solutions for patients with brain tumours: Intra-arterial delivery of chemotherapeutic agents improves survival
The use of intra-arterial delivery for the treatment of malignant brain tumours is safe and provides clinical benefits in terms of survival when used...
New trial investigating combination therapy of radioembolization and immunotherapy in HCC patients launches
The Society of Interventional Oncology (SIO) and Boston Scientific have announced a new multicentre, prospective, randomised trial to study combination therapy of radioembolization and...
Personalised treatment planning “the future” of radioembolization, ECIO hears, in Y-90 vs. Ho-166 comparison
Personalised treatment selection and planning based on controlled dosimetry will lead to improvements in treatment accuracy. This is the conclusion presented by Marnix Lam...
Radioembolization with Y-90 now “a versatile treatment option” for HCC patients of all stages
As presented at the Global Embolization Oncology Symposium Technologies (GEST) 2020 meeting (4–6 September, virtual), Robert Lewandowski discusses the evolution of radioembolization with Yttrium-90...
Sirtex Medical completes enrollment of landmark US RESiN registry
Sirtex Medical reports that enrollment in the US RESiN registry has reached a milestone of 1,650 patients and 12.8 months of follow-up, allowing for...
Terumo acquires Quirem Medical
Terumo Corporation has announced it has completed the acquisition of Quirem Medical, a Netherlands-based healthcare start-up specialising in the development of next-generation microspheres for...
Radioembolization paper publication a “landmark moment” for IR-Hepatology collaboration
The cover of June’s edition of the Journal of Hepatology featured a paper on transarterial radioembolization for the treatment of hepatocellular carcinoma (HCC). Publication...
Matthew Johnson
Inspired by his father, an interventional radiologist who used to shape catheters over the stove at home, Matthew Johnson switched from a residency in...
Combining targeted Holmium-166 radioembolization with systemic therapy improves response rates in bulky liver disease...
This article is sponsored by Terumo.
The first prospective study on the combination of peptide receptor radionuclide therapy (PRRT) with 177Lu-DOTATATE and Holmium-166 (166Ho) radioembolization...
Early clinical results suggest novel ablation modality may stimulate an abscopal immune response in...
Investigators report a 100% technical success rate in creating their planned ablation volume and no major device-related complications in the first-in-human clinical cases using...
FDA clears Artis icono family of angiography systems from Siemens Healthineers
The US Food and Drug Administration (FDA) has cleared the Artis icono, a family of angiography systems from Siemens Healthineers that permit a range...
What is an interventional oncologist?
Society of Interventional Oncology (SIO) president William (Bill) Rilling notes that you do not need to be a full time cancer specialist to describe...
Varian Medical acquires two Boston Scientific product lines
Radiation therapy firm Varian Medical Systems has signed an agreement to acquire Boston Scientific's portfolio of drug-loadable microsphere and bland embolic bead products designed...
IR community backs PAE and calls for close collaboration with urologists
Current evidence supports the use of prostate artery embolization (PAE) as a safe, effective, and minimally-invasive treatment for the symptoms of benign prostatic hyperplasia...
Y-90 radioembolization in hepatocellular carcinoma: “Liver function is key”
Jens Ricke (Department of Radiology, University Hospital LMU Munich, Germany) presented the latest evidence about Y-90 radioembolization in hepatocellular carcinoma (HCC) at the 2019...
FDA grants 510(k) clearance to software suite for molecular imaging and molecular radiotherapy dosimetry
The US Food and Drug Administration (FDA) has granted 510(k) clearance to the company DOSIsoft to market its Planet Onco Dose software, for its...
Patients prefer transradial access to transfemoral, study finds
Patients have a strong preference for transradial access, a recent study published in the Journal of Vascular and Interventional Radiology finds. Lead author Lisa...
Artificial intelligence will cause “paradigm shift” in IR practice
Clinicians are calling for increased collaboration between computer scientists, biomedical engineers and interventional radiologists as machine learning is posited to play a more prominent...
The future of interventional radiology rests on the creativity and innovation that founded the...
Described by her supervisor Glen Schlaphoff (Sydney, Australia) as "a perfect example of a young up and coming interventional radiologist", Sindhura Nirmalarajan is a...
Physicians call for further work on IRE in pancreatic cancer
Further research into the use of percutaneous irreversible electroporation (IRE) in the treatment of pancreatic cancer is essential, according to Govindarajan Narayanan, chief of...
Lessons from randomised controlled trials utilising SIRT in liver cancer
A recent session at CIRSE 2018 sought to go beyond the headline findings from a number of recent randomised controlled trials (RCTs) in interventional...
ICEfx cryoablation system launches globally at CIRSE 2018
BTG has announced the global launch of its ICEfx cryoablation system. This is an evolution of the existing Visual ICE system, and according to...
Top trends in ablation in 2018
Roberto Iezzi provides an overview of ablative therapies, and what interventional radiologists can expect from ablation procedures in the near future. Amongst the emerging...
New augmented reality system lets IRs “literally see through the patient”
European Radiology Experimental has recently published a study on a new augmented reality system that is able to accurately guide interventional oncology procedures. A three-step...
Clinical capabilities of Infinix-i 4D CT showcased at ECR 2018
Healthcare centres around Europe are realising a new realm of clinical efficiency with the Infinix-i 4D CT system, which seamlessly integrates interventional radiology and...
MagForce gets US FDA nod to begin clinical trial evaluating focal ablation for intermediate...
The US FDA’s granting of an investigational device exemption (IDE) allows MagForce to conduct a pivotal clinical evaluating the company’s NanoTherm therapy for intermediate...
Varian signs agreement to acquire Sirtex
Varian Medical has announced it has signed an agreement to acquire all the outstanding shares of Sirtex Medical for A$28 per share in cash....
Andrew Holden
“If you are clinically skilled, achieve a high level of technical training in interventional radiology procedures, have the best audited results for a procedure...
Y-90 experience in HCC crosses 1,000-patient milestone
“We are most enthusiastic about the use of radioembolization to treat patients with early stage Barcelona Clinic Liver Cancer (BCLC) A disease. The long time...
Same day Y-90 treatment could become paradigm of the future
While further refining where radioembolization should optimally lie in current treatment paradigms for the most common liver-confined or liver-dominant cancers is important, a honing...
Bob Abraham
Canada’s recent recognition as a subspecialty at the national level has helped to raise awareness amongst other disciplines, healthcare policymakers and hospital administrators. “We...
The interface of an imaging system should feel “like an extension of a physician’s...
In February, Philips announced the global launch of Azurion, its next generation image-guided therapy platform, which forms the new core of its integrated solutions portfolio....
SIRveNIB abstract published by ASCO, to be presented on 4 June
SIRveNIB is an investigator-led Asia Pacific Primary Liver Cancer Study to be presented on 4 June 2017 at the American Society of Clinical Oncology...
SIRT significantly better tolerated than sorafenib, but does not increase overall survival in hepatocellular...
The 459-patient randomised controlled SARAH study shows that local treatments of advanced or inoperable hepatocellular carcinoma with selective internal radiation therapy (SIRT) did not...
The role of Y-90 radioembolization for cholangiocarcinoma
Y-90 radioembolization is a promising locoregional therapy for a devastating disease with few available treatment options. Ongoing and future clinical trials will help to...
Gireesh Mukund Warawdekar
“Interventional radiology has always been characterised by its innovative spirit. We are now seeing progress with new procedures being developed to create percutaneous arteriovenous fistulae....
SIRT access “under threat” from commissioning through evaluation process
Selective internal radiation therapy (SIRT) has been available since December 2013 to a defined group of patients with liver metastases in England on the...
New ESMO biliary cancer guidelines indicate radioembolization as an option for cholangiocarcinoma
New European Society of Medical Oncology (ESMO) biliary cancer guidelines indicate yttrium-90 (Y-90) therapy as an option for post-chemotherapy treatment of intrahepatic cholangiocarcinoma.
Sirtex has announced...
Coverage of Insightec’s Exablate for pain palliation of bone metastases expands to 99.8 million...
Insightec has announced that Exablate, which uses magnetic resonance-guided focused ultrasound (MRgFUS), for pain palliation of bone metastases in cancer patients is now a...
Positioning microwave antenna at least 5mm from heart may reduce cardiac complications when performing...
Speaking at the World Conference on Interventional Oncology (WCIO; 9–12 June, Boston, USA), George Carberry (University of Wisconsin School of Medicine and Public Health,...
South African health insurer approves reimbursement of SIR-Spheres Y-90 resin microspheres for patients with...
Sirtex has announced that Discovery Health, a South African private health insurer, has agreed to reimburse SIR-Spheres Y-90 resin microspheres for the treatment of all forms of inoperable liver tumours.
SIR-Spheres with chemotherapy can prolong progression-free survival in colorectal cancer of the liver
The addition of SIR-Spheres (Sirtex) to chemotherapy has been shown to significantly prolong progression-free survival in the liver among patients with non-resectable liver-dominant or liver-only colorectal cancer in the SIRFLOX study.
Stents loaded with radioactive iodine attempt to kill two birds with one stone
The development of an irradiating stent combines the rapid, effective relief of dysphagia through endoluminal stent placement with the longer-term benefits of irradiation/brachytherapy.
Gabriel Bartal
“In the early days, I used to have to cut a 7F plastic tube, make side holes, send it off for sterilisation and shape...
BTG and MIRADA collaborate to develop dosimetry software solutions to optimise radioembolization
BTG and Mirada, a medical imaging software company, have announced an important collaboration to develop dosimetry software solutions to optimise radioembolization therapy with TheraSphere.
SIR-Spheres Y-90 resin microspheres and chemotherapy extends progression-free survival of metastatic colorectal cancer in...
Adding SIR-Spheres Y-90 resin microspheres to first-line chemotherapy for patients with unresectable metastatic colorectal cancer in the liver (mCRC) further extends progression-free survival in that organ.
Niche applications of irreversible electroporation
Having performed over 400 irreversible electroporation treatments at the University of Miami, USA, Govindarajan Narayanan believes that certain niche applications of the technology have demonstrated tremendous value and hold a lot of promise for patients.
“We are helping surgeons operate on sicker patients”
Daniel B Brown, professor of Radiology and director, Interventional Oncology, Vanderbilt-Ingram Cancer Center, Nashville, USA, puts together a 2015 checklist on the latest portal...
Intratumoural injections of bacteria result in oncolysis of solid tumours, first-in-man study shows
Results from a phase I study using an attenuated strain of Clostridium novyi (C novyi-NT) show that bacterial spores can be delivered using existing imaging technologies and devices to demonstrate clinical evidence of germination and confirms the capability of inducing oncolysis in human neoplastic tissues.
FOXFIRE and FOXFIRE Global studies complete patient enrolment
Sirtex has announced the completion of patient enrolment in FOXFIRE and FOXFIRE Global, two large multicentre studies that added liver-directed radiation therapy with SIR-Spheres Y-90 resin microspheres to a current standard of care chemotherapy regimen in the first-line treatment of more than 560 patients recently diagnosed with inoperable metastatic colorectal cancer.
Gao-Jun Teng
In the future, will interventional radiology be a subspecialty of radiology, or surgery? asks Gao-Jun Teng, professor of Radiology, Zhongda Hospital, Southeast University, Nanjing,...
The microenvironment of solid tumours matters
By Aravind Arepally
Despite the rapid growth of imaging and treatment options in interventional oncology, one area that has been poorly understood and overlooked by...
Trial shows significant pain relief for spine cancer patients following targeted radiofrequency ablation treatment
DFINE has announced the publication of a multicentre study in the July/August issue of Pain Physician Journal, the official peer-reviewed publication of the American...
Interventional radiology techniques and results for the management of neuroendocrine liver metastases
Interventional radiology techniques are widely performed and useful in liver metastases from neuroendocrine tumours, but the level of scientific proof is paradoxically low, especially...
Cryoablation provides pain relief for patients with metastatic tumours
Cryoablation kills tumours and provides pain relief to patients whose cancer has spread to the bone and soft tissue, suggests research being presented at...
Ten-year Spanish experience shows SIRT achieves disease control in over 80% hepatocellular carcinoma patients
The Clínica Universidad de Navarra (CUN), Pamplona, Spain, recently celebrated its tenth anniversary of using Yttrium-90 (Y-90) microsphere radioembolization for the treatment of liver...
Cost effective prostate cancer treatment underused in the UK
The study, which was presented at the European Society for Radiotherapy and Oncology (ESTRO) 19 to 23 April 2013, Geneva, Switzerland, used the latest cost effectiveness model...
Chuck Ray
Chuck Ray is a professor and vice-chair of radiology at University of Colorado, Colorado, USA. He has served as a Lieutenant Colonel in the...
Varian Medical Systems receives FDA 510(k) clearance for the Edge radiosurgery suite
Varian Medical Systems has received FDA 510(k) clearance for the company’s Edge radiosurgery suite, a new dedicated system for performing advanced radiosurgery using real-time...
Interventional treatment with radioactive beads could help colon cancer patients live longer
Patients who received minimally invasive treatment with yttrium-90 (Y-90) radioactive beads to treat colorectal cancer that had spread to the liver lived almost a...
Large US multicentre study confirms safety and efficacy of SIR-Spheres
SIR-Spheres microspheres are well-tolerated and effective internal radiotherapy for unresectable, heavily pre-treated colorectal cancer liver metastases, according to results from a new study of more...
CT-Guide Needle Guidance System for liver interventions gets FDA clearance
The US Food and Drug Administration (FDA) has given 510(k) clearance to ActiViews to market its CT-Guide Needle Guidance System for liver interventions.
CT-Guide navigation...
Riccardo Lencioni
As a former football referee, Riccardo Lencioni tells Interventional News readers how important it is to respect the rules —how important it is to...
Interventional radiologists in the USA receive approval to serve as authorised users for Y90
Since February 2011, interventional radiologists are authorised users for Y90 therapy. A course organised by the Society of Interventional Radiology in Scottsdale, USA, ‰Û÷Y90: Are YoU Ready?‰Ûª offered a challenging, rigorous curriculum to 106 attendees. Interventional News found out more from the participants.
Society of Interventional Radiology offers course on the treatment of liver tumors
The course Y90: Are You Ready? incorporates the requisite training and testing for official SIR validation of an interventional radiologist attendee as qualified to apply for Authorised User (AU) status for intra-arterial Y90 in the treatment of hepatic malignancies.
First US patient treated with the Accu2i percutaneous microwave tissue ablation device (pMTA)
Innovative and safe system is used to destroy liver tumour
Jan Peregrin
Jan Peregrin, CIRSE president 2009, told Interventional News that the miniaturisation of interventional devices hold great promise and that this will allow many clinical...
SIR president rallies IRs to safeguard embolisation
At GEST USA 2010, James Benenati calls for IRs to get credentialing criteria in place
